|
1
|
Wang ZY and Chen Z: Acute promyelocytic
leukemia: From highly fatal to highly curable. Blood.
111:2505–2515. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
de Botton S, Sanz MA, Chevret S, Dombret
H, Martin G, Thomas X, Mediavilla JD, Recher C, et al European APL
Group; PETHEMA Group: Extramedullary relapse in acute promyelocytic
leukemia treated with all-trans retinoic acid and chemotherapy.
Leukemia. 20:35–41. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Colovic N, Tomin D, Vidovic A, et al:
Central nervous system relapse in CD56+,
FLT3/ITD+ promyelocytic leukemia. Med Oncol. 29:260–262.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wiernik PH, De Bellis R, Muxi P and
Dutcher JP: Extramedullary acute promyelocytic leukemia. Cancer.
78:2510–2514. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ko BS, Tang JL, Chen YC, et al:
Extramedullary relapse after all-trans retinoic acid treatment in
acute promyelocytic leukemia - the occurrence of retinoic acid
syndrome is a risk factor. Leukemia. 13:1406–1408. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Specchia G, Lo Coco F, Vignetti M, et al:
Extramedullary involvement at relapse in acute promyelocytic
leukemia patients treated or not with all-trans retinoic acid: A
report by the Gruppo Italiano Malattie Ematologiche dell'Adulto. J
Clin Oncol. 19:4023–4028. 2001.PubMed/NCBI
|
|
7
|
Ohno R, Asou N and Ohnishi K: Treatment of
acute promyelocytic leukemia: Strategy toward further increase of
cure rate. Leukemia. 17:1454–1463. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Callens C, Chevret S, Cayuela JM, et al
European APL Group: Prognostic implication of FLT3 and Ras gene
mutations in patients with acute promyelocytic leukemia (APL): A
retrospective study from the European APL Group. Leukemia.
19:1153–1160. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kuchenbauer F, Schoch C, Kern W, et al:
Impact of FLT3 mutations and promyelocytic leukemia-breakpoint on
clinical characteristics and prognosis in acute promyelocytic
leukemia. Br J Haematol. 130:196–202. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Barragán E, Montesinos P, Camos M, et al
PETHEMA Group; HOVON Group: Prognostic value of FLT3-mutations in
patients with acute promyelocytic leukemia treated with all-trans
retinoic acid and anthracycline monochemotherapy. Haematologica.
96:1470–1477. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chillón MC, Santamaría C, García-Sanz R,
Balanzategui A, Sarasquete ME, Alcoceba M, Marín L, Caballero MD,
Vidriales MB, Ramos F, Bernal T, et al: Long FLT3 internal tandem
duplications and reduced PML-RARα expression at diagnosis
characterize a high-risk subgroup of acute promyelocytic leukemia
patients. Haematolgica. 95:745–751. 2010. View Article : Google Scholar
|
|
12
|
Gale RE, Hills R, Pizzey AR, Kottaridis
PD, Swirsky D, Gilkes AF, Nugent E, Mills KI, Wheatley K, Solomon
E, et al NCRI Adult Leukaemia Working Party: Relationship between
FLT3 mutation status, biologic characteristics and response to
targeted therapy in acute promyelocytic leukemia. Blood.
106:3768–3776. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schnittger S, Bacher U, Haferlach C, Kern
W, Alpermann T and Haferlach T: Clinical impact of FTL3 mutation
load in acute promyelocytic leukemia with t(15;17)/PML-RARA.
Haematologica. 96:1799–1807. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bacher U, Haferlach C, Kern W, Haferlach T
and Schnittger S: Prognostic relevance of FTL3-TKD mutations in
AML: The combination matters - an analysis of 3082 patients. Blood.
111:2527–2737. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gaur GC, Ramadan SM, Cicconi L, Noguera
NI, Luna I, Such E, et al: Analysis of mutational status, SNP
rs16754, and expression levels of Wilms tumor 1 (WT1) gene in acute
promyelocytic leukemia. Ann Hematol. 91:1855–1860. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hou HA, Huang TC, Lin LI, Liu CY, Chen CY,
Chou WC, Tang JL, Tseng MH, Huang CF, Chiang YC, et al: WT1
mutation in 470 adult patients with acute myeloid leukemia:
Stability during disease evolution and implication of its
incorporation into a survival scoring system. Blood. 115:5222–5231.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shih LY, Kuo MC, Liang DC, Huang CF, Lin
TL, Wu JH, Wang PN, Dunn P and Lai CL: Internal tandem duplication
and Asp835 mutations of the FMS-like tyrosine kinase 3 (FLT3) gene
in acute promyelocytic leukemia. Cancer. 98:1206–1216. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kutny MA, Moser BK, Laumann K, Feusner JH,
Gamis A, Gregory J, Larson RA, Powell BL, Stock W, Willman CL, et
al: FLT3 mutation status is a predictor of early death in pediatric
acute promyelocytic leukemia: A report from the Children's Oncology
Group. Pediatr Blood Cancer. 59:662–667. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tashiro H, Shirasaki R, Oka Y, Sugao T,
Mizutani-Noguchi M, Yamamoto T, Akiyama N, Kawasugi K and Shirafuji
N: FLT3 internal tandem duplication is associated with a high
relapse rate and central nervous system involvement in acute
promyelocytic leukemia cases: Single institutional analysis. Eur J
Haematol. 86:272–273. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Montesinos P, Díaz-Mediavilla J, Debén G,
Prates V, Tormo M, Rubio V, Pérez I, Fernández I, Viguria M, Rayón
C, et al: Central nervous system involvement at first relapse in
patients with acute promyelocytic leukemia treated with all-trans
retinoic acid and anthracycline monochemotherapy without
intrathecal prophylaxis. Haematologica. 94:1242–1249. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nagai S, Nannya Y, Arai S, Yoshiki Y,
Takahashi T and Kurokawa M: Molecular or cytogenetic monitoring and
preemptive therapy for central nervous system relapse of acute
promyelocytic leukemia. Haematologica. 95:169–171. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bae SH, Ryoo HM, Cho HS, Lee JL, Lee KH
and Hyun MS: Meningeal relapse in a patient with acute
promyelocytic leukemia: A case report and review of the literature.
J Korean Med Sci. 19:311–314. 2004. View Article : Google Scholar : PubMed/NCBI
|
